ArticleFrontiers in oncology2026

Correction: Case Report: Complete response and prolonged survival to alectinib in a NSCLC patient with metastases harboring a rare WDR43::ALK structural deletion.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.